logo
Explore dividend stocks
Add to watchlist
€89.8
Last updated:04/19/2021
4AB: F
AbbVie Inc

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK … Show more

Dividend yield
4.37%
€3.92 anually

3y growth is 14.66%

P/E ratio
39.56x
vs. 8.71x forward

Price is 39.56x times more than EPS €2.27 which eaquals €89.8

Payout ratio
172.73%
Yearly

172.73% of earnings is used as dividends.

CASH payout ratio

Last quarter

Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company debt level

Become our supporter to unlock all data!
4AB dividends
Payout frequency
quarter
Latest ex-date
01/14/2021
3y growth
14.66%
5y growth
21.76%
2021
€1.08
01/14/2021
$1.3
2020
Increase
€3.92
10/14/2020
$1.18
07/14/2020
$1.18
04/14/2020
$1.18
01/14/2020
$1.18
2019
Increase
€3.55
10/11/2019
$1.07
07/12/2019
$1.07
04/12/2019
$1.07
01/14/2019
$1.07
2018
€2.98
10/12/2018
$0.96
07/12/2018
$0.96
04/12/2018
$0.96
01/11/2018
$0.71
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
5.309B
5.687B
+7.12%
7.882B
+38.60%
4.616B
-41.44%
Cashflow
Sum up money going in and out company
9.96B
13.427B
+34.81%
13.324B
-0.77%
17.588B
+32.00%
Total liabilities
All combined debts and obligations
65.689B
67.798B
+3.21%
97.287B
+43.50%
137.468B
+41.30%
Company profile
CEO
Mr. Richard A. Gonzalez
Market capitalization
Mega (158.19B)